News
Expanded hospital testing improves respiratory pathogen detection
December 8, 2017
More in depth testing greatly increased viral detection in respiratory patients
News
Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
December 6, 2017
The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.
News
ABIM to allow do-overs for all subspecialties with Knowledge Check-In
December 6, 2017
The option had been available only for internal medicine and nephrology.
News
Alarm reductions don’t improve ICU response times
December 5, 2017
TORONTO – Cutting back alarm numbers in the ICU did not lead to better alarm-response times at Harlem Hospital.
News
Benefit of dabigatran over warfarin persists in AF patient subgroups undergoing PCI
December 3, 2017
ANAHEIM, CALIF. – Dabigatran protected against thromboembolic events with less bleeding regardless of stent type, type of concomitant treatment, or indication for PCI.
News
New buprenorphine formulation approved for medication-assisted treatment
December 2, 2017
Patients who are currently taking other buprenorphine formulations can be transitioned.
News
Observing BP measurement made no difference in SPRINT
November 28, 2017
ANAHEIM, CALIF. – It didn’t matter whether BP measurements were observed or not; blood pressure control and outcomes were largely the same either way.
News
Heart failure readmission penalties linked with rise in deaths
November 18, 2017
Heart failure readmissions penalties linked with rise in deaths ANAHEIM, CALIF. – Evidence continues to mount that Medicare’s penalization of hospitals with excess heart failure readmissions has cut readmissions but at the apparent price of more deaths.During the penalty phase of...
News
Two changes are made to resuscitation practice in delivery room
November 17, 2017
One is in regard to heart rate assessment, the other to meconium.
News
Prescribers mostly ignore clopidogrel pharmacogenomic profiling
November 16, 2017
ANAHEIM, CALIF. – Physicians treating ACS patients with an antiplatelet all but ignore their genetically assessed ability to metabolize clopidogrel.